Stryker to Acquire Inari Medical in $4.9B Deal, Expanding Leadership in Peripheral Vascular Care
Portage, MI and Irvine, CA, January 06, 2025 (Globe Newswire) -- Stryker’s acquisition of Inari Medical for $4.9 billion reinforces its leadership in medical technologies by expanding its portfolio to include innovative solutions for venous thromboembolism. Inari’s complementary product offerings align with Stryker’s Neurovascular business and will enhance its ability to address unmet patient needs in the fast-growing peripheral vascular market. The deal, expected to close in early 2025, underscores Stryker’s commitment to advancing endovascular care globally.
Read full article here.